A Randomized Phase IIB Study of Nivolumab or Nivolumab in Combination with Ipilimumab versus Bevacizumab in Adult Subjects with Recurrent Glioblastoma

Conditions

Brain and Nervous System

What is the purpose of this trial?

The purpose of the study is to understand the safety, tolerability and efficacy of Nivolumab as a single agent or in combination with Ipilimumab versus Bevacizumab in patients diagnosed with Recurrent Glioblastoma (GBM).


Participation Guidelines

Age:
Gender:

Click here for detailed information about who can participate in this trial.


Sponsor:
Bristol-Myers Squibb Company
Dates:
02/21/2014
Last Updated:
Study HIC#:
1312013141